225 related articles for article (PubMed ID: 22332960)
61. The use of clobazam as an adjunctive treatment for Lennox-Gastaut syndrome.
Owen RT
Drugs Today (Barc); 2012 Nov; 48(11):697-703. PubMed ID: 23170305
[TBL] [Abstract][Full Text] [Related]
62. Topiramate: a review of its use in childhood epilepsy.
Ormrod D; McClellan K
Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
[TBL] [Abstract][Full Text] [Related]
63. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
[TBL] [Abstract][Full Text] [Related]
64. Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review.
Balagura G; Riva A; Marchese F; Verrotti A; Striano P
Neuropsychiatr Dis Treat; 2020; 16():369-379. PubMed ID: 32103957
[TBL] [Abstract][Full Text] [Related]
65. Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome.
Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Verrotti A; D'Aniello A; Mangano S; Balestri A; Curatolo P; Pascotto A
Eur J Neurol; 2011 Feb; 18(2):246-251. PubMed ID: 20666837
[TBL] [Abstract][Full Text] [Related]
66. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
67. [Effectiveness and safety of rufinamide at treatment of epilepsy with complications and drug-resistant epilepsy (according to meta-analysis data)].
Mazin PV; Sheshunov IV; Kislitsyn YV; Mazina NK
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):40-43. PubMed ID: 27635610
[TBL] [Abstract][Full Text] [Related]
68. Valproate treatment after liver transplant in a patient with Lennox-Gastaut syndrome.
Velizarova R; Gelisse P; Pageaux GP; Genton P; Crespel A
Seizure; 2011 Jul; 20(6):500-1. PubMed ID: 21376637
[TBL] [Abstract][Full Text] [Related]
69. Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study.
Kluger G; Glauser T; Krauss G; Seeruthun R; Perdomo C; Arroyo S
Acta Neurol Scand; 2010 Sep; 122(3):202-8. PubMed ID: 20199521
[TBL] [Abstract][Full Text] [Related]
70. A granulocytosis associated with rufinamide: A case report.
Ide M; Kato T; Nakata M; Saito K; Yoshida T; Awaya T; Heike T
Brain Dev; 2015 Sep; 37(8):825-8. PubMed ID: 25619447
[TBL] [Abstract][Full Text] [Related]
71. Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome.
Kessler SK; McCarthy A; Cnaan A; Dlugos DJ
Epilepsy Res; 2015 May; 112():18-26. PubMed ID: 25847334
[TBL] [Abstract][Full Text] [Related]
72. Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis.
Devi N; Madaan P; Ameen R; Sahu JK; Bansal D
Seizure; 2022 Jul; 99():164-175. PubMed ID: 35487871
[TBL] [Abstract][Full Text] [Related]
73. Aggravation of atonic seizures by rufinamide: A case report.
Bektaş G; Çalışkan M; Aydın A; Pembegül Yıldız E; Tatlı B; Aydınlı N; Özmen M
Brain Dev; 2016 Aug; 38(7):654-7. PubMed ID: 26906013
[TBL] [Abstract][Full Text] [Related]
74. Efficacy of rufinamide in drug-resistant epilepsy: a meta-analysis.
Verrotti A; Loiacono G; Ballone E; Mattei PA; Chiarelli F; Curatolo P
Pediatr Neurol; 2011 May; 44(5):347-9. PubMed ID: 21481742
[TBL] [Abstract][Full Text] [Related]
75. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
76. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
[TBL] [Abstract][Full Text] [Related]
77. Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies.
Wheless JW; Conry J; Krauss G; Mann A; LoPresti A; Narurkar M
J Child Neurol; 2009 Dec; 24(12):1520-5. PubMed ID: 19955344
[TBL] [Abstract][Full Text] [Related]
78. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
[TBL] [Abstract][Full Text] [Related]
79. Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
Knupp KG; Scheffer IE; Ceulemans B; Sullivan J; Nickels KC; Lagae L; Guerrini R; Zuberi SM; Nabbout R; Riney K; Agarwal A; Lock M; Dai D; Farfel GM; Galer BS; Gammaitoni AR; Polega S; Davis R; Gil-Nagel A
Epilepsia; 2023 Jan; 64(1):139-151. PubMed ID: 36196777
[TBL] [Abstract][Full Text] [Related]
80. Update on rufinamide in childhood epilepsy.
Coppola G
Neuropsychiatr Dis Treat; 2011; 7():399-407. PubMed ID: 21792306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
